Description

Rapimig (zolmitriptan) dispersible tablets 2,5 mg. №6

Ingredients:

Each dispersible tablet contains 2.5 mg of zolmitriptan.

Dosage:

The recommended dosage is one tablet at the onset of a migraine headache. Do not exceed more than 2 tablets in a 24-hour period.

Indications:

Rapimig dispersible tablets are indicated for the acute treatment of migraine attacks with or without aura.

Contraindications:

Do not use Rapimig if you have uncontrolled hypertension, ischemic heart disease, or have taken ergotamine derivatives within the last 24 hours.

Directions:

Place the tablet on your tongue and allow it to disintegrate, then swallow with saliva. No water is needed.

Scientific Evidence:

Zolmitriptan, the active ingredient in Rapimig, is a selective serotonin receptor agonist that works by constricting blood vessels in the brain, thereby reducing migraine symptoms. Clinical studies have shown zolmitriptan to be effective in relieving migraine pain and associated symptoms within 2 hours of administration.

A study published in the Journal of Headache and Pain demonstrated the efficacy of zolmitriptan dispersible tablets in providing rapid relief from migraine attacks with a low incidence of recurrence. The study concluded that zolmitriptan is a valuable option for the acute treatment of migraines.

Additional Information:

• Storage: Store at room temperature away from moisture and heat.
• Side Effects: Common side effects may include dizziness, drowsiness, and nausea.
• Precautions: Inform your healthcare provider of any other medications you are taking before using Rapimig.